These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28815989)
1. Can we improve risk communication about non-invasive prenatal testing? Petrova D; Garcia-Retamero R BJOG; 2018 Feb; 125(3):272-276. PubMed ID: 28815989 [No Abstract] [Full Text] [Related]
2. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
3. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome. Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976 [TBL] [Abstract][Full Text] [Related]
5. What are the goals of prenatal genetic testing? Dukhovny S; Norton ME Semin Perinatol; 2018 Aug; 42(5):270-274. PubMed ID: 30195989 [TBL] [Abstract][Full Text] [Related]
7. A questionnaire study of women's views regarding the effectiveness of serum Down screening in north west Wales. Bulman J; Nan A; Markland MH; Al-Safi W; Leeson S J Obstet Gynaecol; 2004 Jan; 24(1):33-9. PubMed ID: 14675978 [TBL] [Abstract][Full Text] [Related]
8. On the current dilemma of Down syndrome screening. Rose NC Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031 [No Abstract] [Full Text] [Related]